CRX(Bionor)

N/A

Report date: 2023/05/23 14:03:58
NME

Base Information

Drug NameCRX(Bionor)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHIV envelope protein gp120 inhibitorsC-X-C motif chemokine receptor 4 antagonistsC-C chemokine receptor type 5 antagonists
TargetsHIV envelope protein gp120C-X-C motif chemokine receptor 4C-C chemokine receptor type 5
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBionor Pharma
China Registration ClassN/A

Develop Information

Active CompaniesBionor Pharma
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A